POAI — Predictive Oncology Balance Sheet
0.000.00%
- $4.27m
- -$0.89m
- $1.78m
- 54
- 37
- 16
- 28
Annual balance sheet for Predictive Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.151 | 0.678 | 28.2 | 22.1 | 8.73 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.297 | 0.257 | 0.354 | 0.331 | 0.334 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.798 | 1.51 | 29.5 | 23.4 | 10.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.24 | 5.22 | 3.33 | 2.05 | 3.96 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 22.4 | 13.1 | 43.8 | 25.7 | 14.4 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10.9 | 9.34 | 3.24 | 3.88 | 3.95 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 11.1 | 10.4 | 3.51 | 3.97 | 6.15 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 11.2 | 2.64 | 40.3 | 21.8 | 8.27 |
Total Liabilities & Shareholders' Equity | 22.4 | 13.1 | 43.8 | 25.7 | 14.4 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |